USPI 1Q Financial Results & Development Activity: 5 Key Points
1. Consolidated net revenues of $145.3 million for the first quarter of 2014, compared to $145.1 million during the same period in 2013. "This was a challenging start to 2014 for USPI, with a combination of severe weather in certain markets and continuing change in insurance plan design impacting first quarter volumes," said USPI CEO William Wilcox, in the report.
2. The company's operating income slid 18 percent from $58.2 million the first quarter of 2013 to $47.6 million. The company attributed its flat revenues to a 3.1 percent decline in same-store cases and the drop in operating income to significant investments in its infrastructure.
3. Cash flow from operating activities was $61 million this quarter, compared to $38.6 million in the prior year period. Though the company had a relatively slow start to the year, it did exhibit active development plans.
4. USPI acquired two facilities in the first quarter of 2014 and acquired another after the end of the quarter. USPI owns and operates 216 facilities, 148 of which are joint ventures with not-for-profit healthcare systems.
5. The company intends to acquire five to 10 additional facilities during the rest of the year. The company closed one facility in the first quarter. "We remain comfortable with our long-term strategy, optimistic about our development pipeline and believe the capabilities we are building will be beneficial long term to our partnerships with prominent health systems and physicians," said Mr. Wilcox.
More Articles on Transactions and Valuation Issues:
4 Recent ASC Acquisitions, Mergers & Conversions
ASCs vs. HOPDs: 4 Unexpected Consequences of Rate Equalization
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- 7 things for ASC leaders to know for Thursday — Jan. 19, 2017
- North America leads global infection control market with 39.5% market share: 5 takeaways
- 'Nightmare bacteria ' making its way across US facilities baffles researchers: 4 things to know
- Allergan to pay $15M fine for not disclosing 2014 merger talks in timely manner & more— 6 GI company key notes
- 10 ASC revenue cycle trends and developments to watch in 2017